CDXSNasdaqIndustrial Organic ChemicalsFiscal year ends December 31

CODEXIS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$1.32+0.08 (+6.45%)

Close on Oct 19, 2026

Market cap: $120.19M
P/E (TTM): –
Dividend yield: –

Dividends

Codexis has not reported a dividend

No dividend per share appears in Codexis's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Codexis's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CDXS.

Revenue growth35.9% · median 37.0%

Gross margin87.0% · median 47.3%

Operating margin-35.6% · median -40.9%

Net margin-39.6% · median 1.8%

Company	Revenue	Growth
GEVO	$177.51M	+121.4%
FF	$153.21M	-7.6%
PLX	$80.62M	+30.1%
CDXS	$77.68M	+35.9%
LNZA	$58.31M	+43.8%
CNEY	–	–

Company

Next earnings (est.): Nov 5, 2026, after close
Exchange: Nasdaq
Industry: Industrial Organic Chemicals
Fiscal year ends: December 31
Employees: 146
Held by institutions: 63.7%
Auditor: KPMG LLP
SEC CIK: 1200375

Advertisement
300 × 250